Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Pfizer
Related studies linked through entity extraction aliases.
Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions
- Status
- COMPLETED
- Phase
- PHASE1
CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 2, Open-Label, Multicenter Study of the GARFT Inhibitor in Patients With Metastatic Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)
- Status
- COMPLETED
- Phase
- PHASE2
Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- NA
Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE2
Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
- Status
- COMPLETED
- Phase
- PHASE4
Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
- Status
- COMPLETED
- Phase
- PHASE4